EAM
ARCT icon

Erste Asset Management’s Arcturus Therapeutics ARCT Stock Holding History

Erste Asset Management’s Portfolio ARCT Stock Details ARCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-6,200
Closed -$241K – 554
2021
Q4 		$241K Hold
6,200
– – ﹤0.01% 484
2021
Q3 		$290K Hold
6,200
– – 0.01% 454
2021
Q2 		$214K Hold
6,200
– – ﹤0.01% 468
2021
Q1 		$240K Hold
6,200
– – 0.01% 442
2020
Q4 		$263K Buy
+6,200
New +$420K 0.01% 433

Other funds holding ARCT

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Erste Asset Management's ARCT Position: Q1 2022 in Review

Erste Asset Management sold out of Arcturus Therapeutics (ARCT) in Q1 2022, closing a stake of 6,200 shares — an estimated $241K sold.

Erste Asset Management first reported a position in ARCT in Q4 2020 and held it in 5 quarters. The position peaked at $290K in Q3 2021. 130 funds tracked by Wall St. Rank hold ARCT as of Q1 2022.

  • Erste Asset Management reported no remaining Arcturus Therapeutics position as of Q1 2022 after selling out during the quarter.
  • Erste Asset Management sold 6,200 Arcturus Therapeutics shares in Q1 2022, an estimated $241K.
  • Erste Asset Management first reported a position in Arcturus Therapeutics in Q4 2020 and held it in 5 quarters.
  • Erste Asset Management's Arcturus Therapeutics position peaked at $290K in Q3 2021.
  • 130 funds tracked by Wall St. Rank held Arcturus Therapeutics as of Q1 2022.

Based on Erste Asset Management's 13F filing for Q1 2022, filed 25 Nov 2024.